Deferoxamine B
Deferoxamine B Brand names, Deferoxamine B Analogs
Deferoxamine B Brand Names Mixture
- No information avaliable
Deferoxamine B Chemical_Formula
C20H29N3O2
Deferoxamine B RX_link
No information avaliable
Deferoxamine B fda sheet
Deferoxamine B msds (material safety sheet)
Deferoxamine B Synthesis Reference
No information avaliable
Deferoxamine B Molecular Weight
343.463 g/mol
Deferoxamine B Melting Point
99-101oC (HCl salt)
Deferoxamine B H2O Solubility
42 mg/L
Deferoxamine B State
Solid
Deferoxamine B LogP
3.588
Deferoxamine B Dosage Forms
Ointment
Deferoxamine B Indication
For production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks.
Deferoxamine B Pharmacology
Dibucaine is an amide-type local anesthetic, similar to lidocaine.
Deferoxamine B Absorption
In general, ionized forms (salts) of local anesthetics are not readily absorbed through intact skin. However, both nonionized (bases) and ionized forms of local anesthetics are readily absorbed through traumatized or abraded skin into the systemic circulation.
Deferoxamine B side effects and Toxicity
Subcutaneous LD50 in rat is 27 mg/kg. Symptoms of overdose include convulsions, hypoxia, acidosis, bradycardia, arrhythmias and cardiac arrest.
Deferoxamine B Patient Information
No information avaliable
Deferoxamine B Organisms Affected
Humans and other mammals
